SEARCH RESULT

Total Matching Records found : 345

Is the govt. doing enough for the Jan Aushadhi scheme?

On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...

More »

Experts write to PM against WTO proposal on COVID-19 vaccine waivers -Jacob Koshy

-The Hindu “The current version of the text added new burdensome conditions that would impose additional limits on countries using non-voluntary licensing” Six experts from India, South Africa and the United States have written to Prime Minister Narendra Modi to reject the current version of a proposal at the World Trade Organisation on intellectual property waivers for COVID-19 medicines, that includes vaccines, drugs and diagnostics. In October 2020, at the WTO’s Trade Related...

More »

Household Out-Of-Pocket expenses on health services push 55 million into poverty in India: WHO report -Kavita Bajeli-Datt

-The New Indian Express A significant share, almost two-thirds of OOP expenses, are for purchasing outpatient care, especially medicines. NEW DELHI: Household Out-Of-Pocket (OOP) expenses on health services, especially medicines, continue to push over 55 million people in India into poverty, with over 18 per cent of households incurring catastrophic levels of health expenditures annually, says a WHO report. Despite India’s billing as the ‘pharmacy of the world,’ its population’s Access to Medicines...

More »

‘Compromise’ on TRIPS waiver is a sellout -Latha Jishnu

-Down to Earth Tough new conditions emerge in the compromise deal to ease WTO intellectual property barriers to production of COVID-19 medical tools We are back to square one. Back to the beginning after 18 months of a wearying, tortuous series of negotiations that carried on while millions of lives hung in the balance — and still do. The waiver of intellectual property (IP) rights on medicines, vaccines and diagnostics to fight the...

More »

Voluntary Licensing Agreements between MPP and Big Pharma – Increasing Monopoly Power -Richa Chintan

-Newsclick.in The recent agreements between Medicine Patent Pool and Big Pharma are being projected as benevolent gestures from pharma companies in sharing their patented technologies with other countries. The fact is it is working towards cementing its monopoly power further. The development of anti-viral oral pills to combat COVID-19 will, hopefully, make the fight against the pandemic more promising. While Merck has developed the anti-viral pill Molnupiravir, Pfizer has come up with...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close